Medicine for treating lobular hyperplasia of mammary glands
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of mammary gland hyperplasia and drugs, which is applied in the direction of drug combination, medical raw materials derived from mollusks, and pharmaceutical formulas, can solve the problems of mammary gland hyperplasia that can recur, cannot completely disappear, and cannot be completely cured, so as to improve the body's immunity, Endocrine balance, non-toxic side effects
Inactive Publication Date: 2015-05-27
高文武
View PDF2 Cites 3 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
Such as 1. Completely cure the problem: the current treatment is basically symptomatic treatment, which can only shrink the hyperplastic tissue, but cannot completely disappear. Mammary gland hyperplasia may recur and cannot be completely cured
2. Immunity: How to improve the body's immunity and avoid the invasion of pathogenic factors is a difficult problem for every medical worker
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0008] It is prepared from Bupleurum chinensis, red peony root, white peony root, Atractylodes macrocephala, Poria cocos, Pinellia pinellia, Qingpi, Angelica sinensis, safflower, Zhebei, Gualou, loofah, wangbuliuxing and raw oysters. Its components (weight %) are Bupleurum 5, Chishao 14, Baishao 14, Atractylodes 10, Poria 5, Pinellia 3, Qingpi 5, Angelica 5, Safflower 5, Zhebei 5, Trichosanthes 5, Loofah 4, Wang Buliuxing 5, raw oysters 15. Take 212 grams of the above-mentioned 14 flavors of raw materials, cut the above-mentioned 14 flavors of Chinese herbal medicine into slices or segments at room temperature, add water to 900-1100ml, soak for 4 hours, then boil with strong fire and simmer for 60-80 minutes, remove the residue to obtain 300ml of filtrate About 300ml of water is added to the dregs of the medicine, decocted for 30 minutes, and about 100ml of the filtrate is obtained after removing the dregs, and a total of about 400ml is obtained. Installed in a graduated ster...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention relates to the field of medicine formulas, and in particular relates to a medicine for treating lobular hyperplasia of mammary glands. The medicine is technically characterized by being prepared from the following raw material medicines in percentage by weight: 4-6% of Chinese thorowax root, 13-15% of red paeony root, 13-15% of white paeony root, 8-10% of largehead atractylodes rhizome, 4-6% of Indian buead, 2-4% of pinellia tuber, 3-5% of green tangerine peel, 4-6% of Chinese angelica, 4-6% of safflower, 3-5% of bulb of thunberg fritillary, 4-6% of snakegourd fruit, 3-5% of towel gourd vegetable sponge, 3-5% of cowherb seed and 13-15% of raw oyster shell. A preparation method comprises the following steps: soaking the raw material medicines into water, decocting, and then removing residues to obtain a filtrate. The medicine disclosed by the invention is low in cost, has high curative effects on treatment of lobular hyperplasia of mammary glands, cannot cause toxic or side effects, has the functions of discharging the liver and relieving depression, invigorating the spleen and reducing phlegm, promoting qi circulation and dredging collaterals, activating blood and nourishing blood, softening hardness and dissipating stagnation, enhancing the body immunity, balancing the internal secretion and eliminating the hyperplastic tissues, and is suitable for treating various types of lobular hyperplasia of mammary glands.
Description
technical field [0001] The invention relates to a Chinese patent medicine preparation, in particular to a medicine for breast lobular hyperplasia. Background technique [0002] As we all know, hyperplasia of mammary glands is mainly benign hyperplasia of breast interstitium, hyperplasia can occur around glandular ducts and accompanied by cysts of different sizes; it can also occur in glandular ducts and manifest as epithelial papillary hyperplasia, accompanied by milk duct cysts sexual expansion. In addition, there is a type of lobular parenchymal hyperplasia. The etiology and pathogenesis of mammary gland hyperplasia are related to endocrine disorders and mental factors. The external environment of human existence, work and living conditions, interpersonal relationships, neuropsychological factors caused by various pressures, etc. can change the internal environment of the human body, thereby Affecting the function of the endocrine system, and then causing abnormal secret...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.